Rankings
▼
Calendar
ZYME Q4 2018 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena
ZYME
Zymeworks Inc.
$2B
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$29M
-42.2% YoY
Gross Profit
$15M
50.6% margin
Operating Income
$9M
29.5% margin
Net Income
$9M
32.1% margin
EPS (Diluted)
$0.29
QoQ Revenue Growth
+1308.2%
Cash Flow
Operating Cash Flow
$50M
Free Cash Flow
$50M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$244M
Total Liabilities
$64M
Stockholders' Equity
$180M
Cash & Equivalents
$42M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$29M
$50M
-42.2%
Gross Profit
$15M
$38M
-61.5%
Operating Income
$9M
$33M
-74.4%
Net Income
$9M
$33M
-71.7%
Revenue Segments
Service, Other
$279,000
100%
← FY 2018
All Quarters
Q1 2019 →